Working night shifts disrupts the body’s circadian rhythm, which a number of studies have found may raise the risk of cancer development. Now, researchers have shed light on the mechanisms behind this association. Researchers have shed light on how shift … Read More »
Based on data from the Cancer Genome Atlas (TCGA) program, a multi-agency team of scientists completed the first large-scale breast cancer “protein genomics” (proteogenomic) study, some of the DNA mutation and protein signals linked together, and help determine Some drivers … Read More »
University of Edinburgh May 23 release the results of a study, a team led by university researchers to find a compound that in a lab environment effectively inhibit the growth of breast cancer cells. Based on this finding the scientists … Read More »
Although breast cancer is the most common cause of cancer death among women worldwide, the mortality rate of ovarian cancer is the fifth leading cause of cancer death for women of a significant source. These facts reflect in cancer treatment … Read More »
Recently, an international journal published in The Journal of Clinical Investigation on research papers, researchers from Cardiff University through the study found, the pathogenesis of the bacteria or by inducing the immune system to destroy the insulin-producing cells in type … Read More »
Recently, researchers from the Dana-Farber Cancer Institute in the United States in the international academic journal PNAS reported that a new study their progress, through their study of the natural characteristics of immune cells found for cancer immunotherapy the new … Read More »
Remember the game Operation? You need to carefully remove the body part without nicking the sides or the buzzer will sound. Only imagine pulling out the funny bone when it’s surrounded by vessels controlling urinary and sexual function. That’s the … Read More »
Among the women inducted into the University of Kansas Hall of Fame on April 14, 2016, was Carol Fabian, MD. Fabian, a professor of medicine at the University of Kansas Medical Center and director of the Breast Cancer Prevention Center … Read More »
Recently, Eisai tumor industrial pipelines harvest great news, Lenvima its anti-cancer drug approved by the FDA for the treatment of advanced renal cell carcinoma (renal cell carcinoma, RCC). Last year, Lenvima (lenvatinib mesylate) in the Americas, Europe, Japan, for the … Read More »
A new study shows that regular health screening and acceptance of different women, male osteoporosis is easy to miss the screening, even if did not miss, also hard to attract male attention. Therefore, the researchers found that men treat bone … Read More »